Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.

Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors. Blood. 2012 Aug 16; 120(7):1367-79.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.